UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Merger Mystery: Why Spend Ever More on Mergers When So Many Fail?

2022

Volltextzugriff (PDF)

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline

The Journal of urology, 2017-09, Vol.198 (3), p.552-559

2017

Volltextzugriff (PDF)

Circulating microRNA signature for the diagnosis of very high-risk prostate cancer

Proceedings of the National Academy of Sciences - PNAS, 2016-09, Vol.113 (38), p.10655-10660

2016

Volltextzugriff (PDF)

Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline

The Journal of urology, 2019-08, Vol.202 (2), p.101097JU0000000000000318-281

2019

Volltextzugriff (PDF)

Degrees of Comment on Keynes on Uncertainty: Review Article on Keynes on Uncertainty and Tragic Happiness: Complexity and Expectations by Anna M. Carabelli

Contributions to political economy, 2023-07, Vol.42 (1), p.6-26

Meeks, J Gay

2023

Volltextzugriff (PDF)

Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes

Nature reviews. Urology, 2020-05, Vol.17 (5), p.259-270

2020

Volltextzugriff (PDF)

Identification of Differential Tumor Subtypes of T1 Bladder Cancer

European urology, 2020-10, Vol.78 (4), p.533-537

2020

Volltextzugriff (PDF)

Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy

Nature medicine, 2018-06, Vol.24 (6), p.758-769

2018

Volltextzugriff (PDF)

The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignancies

Cancer, 2017-06, Vol.123 (11), p.1912-1924

2017

Volltextzugriff (PDF)

Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies

Frontiers in immunology, 2020-06, Vol.11, p.1185

2020

Volltextzugriff (PDF)

The effect of minimally invasive prostatectomy on practice patterns of American urologists

Urologic oncology, 2016-06, Vol.34 (6), p.255.e1-255.e5

2016

Volltextzugriff (PDF)

Emerging therapeutic targets in bladder cancer

Cancer treatment reviews, 2015-02, Vol.41 (2), p.170-178

2015

Volltextzugriff (PDF)

Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer

Genome Biology, 2021-04, Vol.22 (1), p.105-20, Article 105

2021

Volltextzugriff (PDF)

Letter: Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial

The Journal of urology, 2024-10, Vol.212 (4), p.623-624

Meeks, Joshua J.

2024

Volltextzugriff (PDF)

Scanometric MicroRNA Array Profiling of Prostate Cancer Markers Using Spherical Nucleic Acid–Gold Nanoparticle Conjugates

Analytical chemistry (Washington), 2012-05, Vol.84 (9), p.4153-4160

2012

Volltextzugriff (PDF)

Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer

Nature communications, 2023-04, Vol.14 (1), p.2126-19, Article 2126

2023

Volltextzugriff (PDF)

Sox3 Is Required for Gonadal Function, but Not Sex Determination, in Males and Females

Molecular and Cellular Biology, 2003-11, Vol.23 (22), p.8084-8091

2003

Volltextzugriff (PDF)

T1 bladder cancer: current considerations for diagnosis and management

Nature reviews. Urology, 2019-01, Vol.16 (1), p.23-34

2019

Volltextzugriff (PDF)

Genomic characterization of high-risk non-muscle invasive bladder cancer

Oncotarget, 2016-11, Vol.7 (46), p.75176-75184

2016

Volltextzugriff (PDF)

Diagnostic Value of Guided Biopsies: Fusion and Cognitive-registration Magnetic Resonance Imaging Versus Conventional Ultrasound Biopsy of the Prostate

Urology (Ridgewood, N.J.), 2016-06, Vol.92, p.75-79

2016

Volltextzugriff (PDF)

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

Nature communications, 2021-04, Vol.12 (1), p.2301-18, Article 2301

2021

Volltextzugriff (PDF)

Incidence and outcomes of ductal carcinoma of the prostate in the USA: analysis of data from the Surveillance, Epidemiology, and End Results program

BJU international, 2012-03, Vol.109 (6), p.831-834

2012

Volltextzugriff (PDF)

Design of a MCoTI-Based Cyclotide with Angiotensin (1-7)-Like Activity

Molecules (Basel, Switzerland), 2016-01, Vol.21 (2), p.152-152

2016

Volltextzugriff (PDF)

Spatial comparison of molecular features associated with resistance to pembrolizumab in BCG unresponsive bladder cancer

Journal for immunotherapy of cancer, 2024-04, Vol.12 (4), p.e008571

2024

Volltextzugriff (PDF)

Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004–2013)

Urologic oncology, 2018-05, Vol.36 (5), p.237.e9-237.e17

2018

Volltextzugriff (PDF)

1 – 25 von 1.520

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.318)
Mit Volltextzugriff
(1.177)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(834)
Life Sciences & Biomedicine
(728)
Humans
(558)
Male
(293)
Female
(257)
Biological And Medical Sciences
(225)
Medical Sciences
(166)
Middle Aged
(149)
Aged
(145)
Urology & Nephrology
(135)
Adult
(111)
Animals
(105)
Urology
(93)
Oncology
(92)
Social Sciences
(75)
Radiology, Nuclear Medicine & Medical Imaging
(74)
Fundamental And Applied Biological Sciences. Psychology
(70)
Technology
(66)
Adolescent
(65)
Geriatrics & Gerontology
(65)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(7)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

The Merger Mystery: Why Spend Ever More on Mergers When So Many Fail?

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline

Circulating microRNA signature for the diagnosis of very high-risk prostate cancer

Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline

Degrees of Comment on Keynes on Uncertainty: Review Article on Keynes on Uncertainty and Tragic Happiness: Complexity and Expectations by Anna M. Carabelli

Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes

Identification of Differential Tumor Subtypes of T1 Bladder Cancer

Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy

The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignancies

Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies

The effect of minimally invasive prostatectomy on practice patterns of American urologists

Emerging therapeutic targets in bladder cancer

Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer

Letter: Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial

Scanometric MicroRNA Array Profiling of Prostate Cancer Markers Using Spherical Nucleic Acid–Gold Nanoparticle Conjugates

Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer

Sox3 Is Required for Gonadal Function, but Not Sex Determination, in Males and Females

T1 bladder cancer: current considerations for diagnosis and management

Genomic characterization of high-risk non-muscle invasive bladder cancer

Diagnostic Value of Guided Biopsies: Fusion and Cognitive-registration Magnetic Resonance Imaging Versus Conventional Ultrasound Biopsy of the Prostate

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

Incidence and outcomes of ductal carcinoma of the prostate in the USA: analysis of data from the Surveillance, Epidemiology, and End Results program

Design of a MCoTI-Based Cyclotide with Angiotensin (1-7)-Like Activity

Spatial comparison of molecular features associated with resistance to pembrolizumab in BCG unresponsive bladder cancer

Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004–2013)

Suchergebnisse filtern